Keyword: Entresto

Novartis

4. Novartis

To focus as what CEO Vas Narasimhan calls “a medicines company,” Novartis made a series of M&A decisions in 2018.
human heart

Special Report—The top 10 cardiovascular drugs in the world

Cardiovascular drugs may not be the top field in terms of sales or market growth rate. But heart disease and related ailments remain the biggest cause of death in the U.S. We’ve put together this list as a state-of-the-market snapshot, coinciding with the European Society of Cardiology meeting this week.